Supraventricular tachycardia after fenoterol inhalation: Report of two cases

Acta Paediatrica Taiwanica

Volumn 44, Issue 3, 2003, Pages 165-167

  Hung, Yu Fa ^a   Yang, Winnie ^a   Chang, Mei Ling ^a  

^a Municipal Yang Ming Hospital   (Taiwan)

Author keywords

Asthma; Fenoterol inhalation; Supraventricular tachycardia

Indexed keywords

ADENOSINE; FENOTEROL; VERAPAMIL;

ARTICLE; ASTHMA; CASE REPORT; CHILD; CLINICAL FEATURE; HUMAN; MALE; METERED DOSE INHALER; PHYSICAL EXAMINATION; SINUS RHYTHM; SUPRAVENTRICULAR TACHYCARDIA; VAGUS NERVE STIMULATION;

ADMINISTRATION, INHALATION; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; FENOTEROL; HUMANS; MALE; METERED DOSE INHALERS; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 0041321164     PISSN: 16088115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Watanabe S, Turner WG, Renzetti AD Jr, Harless KW, Bigler AH, Cutillo A. Bronchodilator effects of nebulized fenoterol: a comparison with isoproterenol. Chest 1981; 80:292-9.
2. O'Donnell SR. An examination of some beta adrenoceptor stimulants for selectivity using the isolated trachea and atria of the guinea pig. Eur J Pharmacol 1972; 19:371-9.
3. Neville E, Corris PA, Vivian J, Nariman S, Gibson GJ. Nebulized salbutamol and angina. Br Med J (Clin Res Ed). 1982; 285:796-7.
4. Walters EH, Cockroft A, Griffiths T, Rocchiccloli K, Davies BH. Optimal dose of Salbutamol respiratory solution: comparison of three doses with plasma levels. Thorax 1981; 36:625-8.
5. Breeden CC, Safirstein BH. Albuterol and spacer induced atrial fibrillation. Chest 1990; 98:762-3.
6. st ed. Baltimore: Williams & Wilkins, 1990; 1809-43.
7. Newhouse MT, Chapman KR, McCallum AI, et al. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma. Chest 1996; 110: 595-603.
8. Lipworth BJ, Newnham DH, Clark RA, Dhillon DP, Winter JH, McDevitt DG. Comparison of the relative airway and systemic potencies of inhaled fenoterol and salbutamol in asthmatic patients. Thorax 1995; 50:54-61.
9. Reilly PA, Yahav J, Mindorff C, Kazim F, Levison H. Dose-response characteristics of nebulized fenoterol in asthmatic children. J Pediatr 1983; 103:121-6.
10. Scalabrin DM, Sole D, Naspitz CK. Efficacy and side effects of beta 2-agonists by inhaled route in acute asthma in children: comparison of salbutamol, terbutaline, and fenoterol. J Asthma 1996; 33:407-15.
11. Duane M, Chandran L, Morelli PJ. Recurrent supraventricular tachycardia as a complication of nebulized albuterol treatment. Clin Pediatr 2000; 39:673-7.
12. Keller KA, Bhisitkul DM. Supraventricular tachycardia: a complication of nebulized albuterol. Pediatr Emerg Care 1995; 11:98-9.
13. Cook P, Scarfone RJ, Cook RT. Adenosine in the termination of albuterol-induced supraventricular tachycardia. Ann Emerg Med 1994; 24:316-9.
14. Kugler JD. Evaluation of pediatric patients with preexcitation syndromes. In: Benditt DG, Benson DW, eds. Cardiac preexcitation syndromes: origins, evaluation and treatment. Boston: Martinus Nijhoff, 1986; 361-411.
15. Kugler JD, Danford DA. Management of infants, children, and adolescents with paroxysmal supraventricular tachycardia. J Pediatr 1996; 129:324-38.